Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

New Treatments Change the Prognosis of Lung Cancer: AstraZeneca

Summary by El Economista
"We are investigating how to combine therapies to make sure that a patient who lived only three months, or perhaps three years, could now live five or ten years," said Sunil Verma, Senior Vice President and Global Director of Oncology Franchise at AstraZeneca.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

El EconomistaEl Economista

New Treatments Change the Prognosis of Lung Cancer: AstraZeneca

"We are investigating how to combine therapies to make sure that a patient who lived only three months, or perhaps three years, could now live five or ten years," said Sunil Verma, Senior Vice President and Global Director of Oncology Franchise at AstraZeneca.

·Mexico City, Mexico
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

El Economista broke the news in Mexico City, Mexico on Thursday, November 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

AstraZeneca icon

AstraZeneca

Mexico icon

Mexico

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal